Back to Trades
Gray Nancy Ryan
DirectorCIK 0001714949
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 2
- Companies
- 1
- Active
- 2025–2026
Gray Nancy Ryan, Director, has filed 2 SEC reports (2025–2026), all concentrated in LIGAND PHARMACEUTICALS INC (LGND), totaling $3.0M in disclosed volume. Weighing $0 bought versus $1.4M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Jun 9 | LGND LIGAND PHARMACEUTICALS INC | Gray Nancy Ryan | Director | Grant | $696.3K |
| Nov 12 | LGND LIGAND PHARMACEUTICALS INC | Gray Nancy Ryan | Director | Sell | $1.4M |
2 filings